(Q46446947)

22 December 2017

title

The effects of bisphosphonates on osteoblasts in vitro (English)

1 reference

22 December 2017

0 references

6

1 reference

22 December 2017

author name string

Aparna Naidu

1

1 reference

22 December 2017

Paul C Dechow

2

1 reference

22 December 2017

Robert Spears

3

1 reference

22 December 2017

John M Wright

4

1 reference

22 December 2017

Harvey P Kessler

5

1 reference

22 December 2017

publication date

27 May 2008

1 reference

22 December 2017

Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics

published in

1 reference

22 December 2017

volume

106

1 reference

22 December 2017

issue

1

1 reference

22 December 2017

page(s)

5-13

1 reference

22 December 2017

Overview of bisphosphonates

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Future directions in the treatment and prevention of bone metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Bisphosphanates and Oral Cavity Avascular Bone Necrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Bisphosphonates: a review of their pharmacokinetic properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

New Insights Into the Molecular Mechanisms of Action of Bisphosphonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

The subcellular distribution of [14C]dichloromethylenebisphosphonate and [14C]1-hydroxyethylidene-1,1-bisphosphonate in cultured calvaria cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

HISTOLOGY OF THE PERIODONTIUM FOLLOWING TOOTH MOVEMENT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Ultrastructural changes in pressure zones of human periodontium incident to orthodontic tooth movement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Zoledronic acid-related angiogenesis modifications and survival in advanced breast cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Long-term effects of neridronate on human osteoblastic cell cultures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Osteoblast proliferation and maturation by bisphosphonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Extracellular signal-regulated kinases and calcium channels are involved in the proliferative effect of bisphosphonates on osteoblastic cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Bisphosphonates stimulate formation of osteoblast precursors and mineralized nodules in murine and human bone marrow cultures in vitro and promote early osteoblastogenesis in young and aged mice in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Bisphosphonates act on rat bone resorption through the mediation of osteoblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Alveolar bone regeneration after removal of inflammatory and traumatic factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Trauma and progression of marginal periodontitis in squirrel monkeys. III Adaption of interproximal alveolar bone to repetitive injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Trauma and progression of marginal periodontitis in squirrel monkeys. IV Reversibility of bone loss due to trauma alone and trauma superimposed upon periodontitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Fever after zoledronic acid administration is due to increase in TNF-alpha and IL-6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Zoledronic-acid-induced circulating level modifications of angiogenic factors, metalloproteinases and proinflammatory cytokines in metastatic breast cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Early events in TNF signaling: a story of associations and dissociations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

The effect of alendronate on cytokine production, adhesion molecule expression, and transendothelial migration of human peripheral blood mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Alendronate/interleukin-1beta cotreatment increases interleukin-6 in bone and UMR-106 cells: dose dependence and relationship to the antiresorptive effect of alendronate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Staphylococcus aureus infection of mouse or human osteoblasts induces high levels of interleukin-6 and interleukin-12 production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Osteoblasts express the inflammatory cytokine interleukin-6 in a murine model of Staphylococcus aureus osteomyelitis and infected human bone tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Bisphosphonates regulate cell growth and gene expression in the UMR 106-01 clonal rat osteosarcoma cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Potential role of cbfa1, an essential transcriptional factor for osteoblast differentiation, in osteoclastogenesis: regulation of mRNA expression of osteoclast differentiation factor (ODF)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Minireview: the OPG/RANKL/RANK system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Mineralization and metabolic response in serially passaged adult rat bone cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Normal and pathological remodeling of human trabecular bone: three dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Bisphosphonates induce breast cancer cell death in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Nitrogen-containing bisphosphonates inhibit cell cycle progression in human melanoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Preclinical studies with zoledronic acid and other bisphosphonates: impact on the bone microenvironment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Bisphosphonates induce apoptosis of stromal tumor cells in giant cell tumor of bone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Effect of alendronate on cultured normal human osteoblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

TGF-beta enhances osteoclast differentiation in hematopoietic cell cultures stimulated with RANKL and M-CSF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Osteoblastic responses to TGF-beta during bone remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Bisphosphonates suppress periosteal osteoblast activity independently of resorption in rat femur and tibia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

Antiremodeling Agents Influence Osteoblast Activity Differently in Modeling and Remodeling Sites of Canine Rib

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2008.03.036

10.1016/J.TRIPLEO.2008.03.036

7 January 2021

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017